From Tuskegee to a COVID Vaccine: Diversity and Racism Are Hurdles in Drug Trials

Article

From Tuskegee to a COVID Vaccine: Diversity and Racism Are Hurdles in Drug Trials

AMID A SEEMINGLY endless pandemic, as a spiraling number of COVID-19 deaths presage what could be a long, dark winter, the news broke through like thin rays of sunshine: Two American pharmaceutical giants racing to find a vaccine separately reported that human tests of their experimental drugs have shown highly promising results.

The potentially game-changing data from drug manufacturers Pfizer and Moderna, however, obscured what some say is another key development: Both companies reported that the pools of volunteers receiving the drugs included significant numbers of Black participants.

Read the full story ... >>

The views and opinions expressed in the article are solely those of their authors, and do not necessarily reflect the opinions and beliefs of DiversityWork.com.